Lupin Receives Tentative USFDA Approval for Generic Pitolisant Tablets
New Delhi, March 25 – Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime...
abbreviated new drug application
drug development
drug manufacturing
excessive daytime sleepiness
generic pharmaceuticals
healthcare
india
lupinltd
nagpur
pharmaceutical approval
pharmaceutical industry
pitolisant
regulatory filings
tablet
us food and drug administration (usfda)
